Altana Acquires Effect Pigments Producer Silberline

Global specialty chemicals group Altana has announced to acquire Silberline, a US company that specializes in developing and manufacturing aluminum effect pigments utilized in various applications, ranging from automotive coatings and printing inks to plastics, protective coatings, and packaged consumer goods.

With the move, Altana said it is strategically expanding its Eckart division and strengthening its regional presence, particularly in North America and Asia. “The acquisition is further proof that we are sustainably implementing our strategy of generating value-creating growth through targeted acquisitions,” commented Martin Babilas, CEO of Altana.

Christian Przybyla, president of Eckart, added: “The local research and production capacities of Silberline and Eckart complement each other perfectly. The merger will enhance our ability to respond flexibly to regional customer needs and further optimize our service quality.”

Gary Karnish, CEO of Silberline, said: “The acquisition of Silberline by Eckart creates new potential. Together, we can more intensively drive the development of sustainable product innovations, benefiting both customers and employees.”

Silberline, headquartered in Tamaqua, Pennsylvania, currently employs over 450 people globally. In 2022, the company achieved sales of approximately $80 million.

The completion of the transaction is subject to customary closing conditions, and both parties have agreed not to disclose the purchase price.

Source: Altana
Source: Altana

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.